Your browser doesn't support javascript.
loading
The views of women and pharmacists on the desirability of a progestogen-only pill over the counter. Results of a survey in Germany, Italy and Spain.
Arisi, Emilio; Bauer, Cosima; Farris, Manuela; Giulini-Limbach, Chiara; Glasier, Anna; Lete, Inaki; May, Uwe; Mirjalili, Noushin; Nappi, Rossella E; Sanchez-Borrego, Rafael; Serrano, Isabel.
Afiliación
  • Arisi E; Department of Obstetrics and Gynecology, 'S. Chiara' Regional Hospital, Trento, Italy.
  • Bauer C; May and Bauer, Lecturer at the Fresenius University of Applied Sciences, Rheinbreitbach, Germany.
  • Farris M; Demographic Education, Sapienza, University of Rome and Italian Association, Rome, Italy.
  • Giulini-Limbach C; May and Bauer, Academic Director at Fresenius University of Applied Sciences, Rheinbreitbach, Germany.
  • Glasier A; Department of Obstetrics and Gynecology, University of Edinburgh, Queen's Medical Research Institute, Midlothian, UK.
  • Lete I; Department of Obstetrics and Gynecology, University Hospital of Araba, Vitoria-Gasteiz, Spain.
  • May U; May and Bauer, Dean of Studies at the Fresenius University of Applied Sciences, Rheinbreitbach, Germany.
  • Mirjalili N; HRA Pharma, Chatillon, France.
  • Nappi RE; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
  • Sanchez-Borrego R; Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause, IRCCS San Matteo Foundation, Pavia, Italy.
  • Serrano I; Diatros Clinic, Diatros Diagnosticos y Tratamientos Avanzados SLP, Barcelona, Spain.
Eur J Contracept Reprod Health Care ; 27(6): 494-503, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36256517
PURPOSE: To explore the perceived need and enthusiasm for over the counter (OTC) progestogen-only pills (POP). MATERIALS AND METHODS: A web-based survey of 1000 sexually active women (16-45) and 100 pharmacists in Germany, Italy and Spain. RESULTS: Despite not wanting to conceive, 5-6% of women in each country were not using contraception and 8-20% were using methods less effective than condoms. At least 74% of respondents felt knowledgeable about the different contraceptives available but at least 1/3 had experienced difficulty accessing oral contraceptive (OCs) in the past two years. The cost of contraceptives, the need to see a doctor and long waits for appointments were cited as barriers for not using OCs. The majority agreed they would discuss with their doctor the decision to buy the POP, consult about side effects and other reproductive health issues. Over 2/3 of pharmacists in each country would be very, or fairly, likely to recommend the POP, agreeing that the benefits included improved access for women, and offered them more independence. CONCLUSIONS: Asked directly, women in Germany, Spain and Italy currently using contraception are positive about a POP OTC. Pharmacists are also positive, with the overwhelming majority in favour of providing POPs.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Farmacéuticos / Progestinas Tipo de estudio: Prognostic_studies Límite: Female / Humans País/Región como asunto: Europa Idioma: En Revista: Eur J Contracept Reprod Health Care Asunto de la revista: MEDICINA REPRODUTIVA / SERVICOS DE PLANEJAMENTO FAMILIAR Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Farmacéuticos / Progestinas Tipo de estudio: Prognostic_studies Límite: Female / Humans País/Región como asunto: Europa Idioma: En Revista: Eur J Contracept Reprod Health Care Asunto de la revista: MEDICINA REPRODUTIVA / SERVICOS DE PLANEJAMENTO FAMILIAR Año: 2022 Tipo del documento: Article País de afiliación: Italia